Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $MURA
Mural Oncology plc
Subscribe to $MURA
$MURA
Biotechnology: Pharmaceutical Preparations
Health Care
IPO Year:
Exchange: NASDAQ
Recent Analyst Ratings for Mural Oncology plc
Date
Price Target
Rating
Analyst
3/25/2025
Overweight → Equal-Weight
Morgan Stanley
3/25/2025
$18.00
Strong Buy → Outperform
Raymond James
6/28/2024
$15.00
Buy
Rodman & Renshaw
4/4/2024
$13.00
Overweight
Morgan Stanley
See more ratings